CG Oncology, Interest Expense Over Time
| CGON Stock | 34.75 0.65 1.91% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CG Oncology, Performance and CG Oncology, Correlation. CGON |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CG Oncology,. If investors know CGON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CG Oncology, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.87) | Revenue Per Share 0.015 | Quarterly Revenue Growth 3.778 | Return On Assets (0.16) | Return On Equity (0.20) |
The market value of CG Oncology, Common is measured differently than its book value, which is the value of CGON that is recorded on the company's balance sheet. Investors also form their own opinion of CG Oncology,'s value that differs from its market value or its book value, called intrinsic value, which is CG Oncology,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CG Oncology,'s market value can be influenced by many factors that don't directly affect CG Oncology,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CG Oncology,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CG Oncology, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CG Oncology,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Interest Expense Analysis
Compare CG Oncology, Common and related stocks such as Patterson UTI Energy, Cheniere Energy Partners, and Drilling Tools Inter Interest Expense Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTEN | 0.0 | 15.7 M | 22.8 M | 28.4 M | 29.8 M | 36.5 M | 40.4 M | 37.5 M | 51.6 M | 75.2 M | 40.8 M | 42 M | 40.3 M | 52.9 M | 55.5 M |
| CQP | 0.0 | 173.6 M | 171.6 M | 178.4 M | 177 M | 184.6 M | 356.9 M | 614 M | 733 M | 885 M | 909 M | 831 M | 870 M | 823 M | 864.1 M |
| DTI | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 477 K | 1.1 M | 749.1 K |
| NRG | 0.0 | 665 M | 661 M | 848 M | 1.1 B | 1.1 B | 1.1 B | 890 M | 483 M | 413 M | 401 M | 485 M | 417 M | 667 M | 564.6 M |
| NBR | 37.6 M | 256.6 M | 251.6 M | 223.4 M | 177.9 M | 181.9 M | 185.4 M | 222.9 M | 227.1 M | 204.3 M | 206.3 M | 171.5 M | 177.9 M | 185.3 M | 130.6 M |
| KNTK | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 83.1 M | 133.5 M | 135.5 M | 117.4 M | 149.3 M | 199.7 M | 112.5 M |
CG Oncology, Common and related stocks such as Patterson UTI Energy, Cheniere Energy Partners, and Drilling Tools Inter Interest Expense description
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.My Equities
My Current Equities and Potential Positions
| CG Oncology, Common | CGON |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 34.75
Check out CG Oncology, Performance and CG Oncology, Correlation. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
CG Oncology, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.